Top Reddit ShortSqueeze Mentions This Weekend: TBLT, GME, BBBY, GOVX, BBIG, XELA, KPLT, EVFM, CHWA, AVCT
$AVCT
$BBBY
$BBIG
$CHWA
EDP Services
Technology
Other Specialty Stores
Consumer Discretionary
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/11/2024 | $15.00 | Buy | Alliance Global Partners | |
| 7/16/2024 | $20.00 | Buy | ROTH MKM | |
| 6/8/2023 | $6.50 → $6.20 | Underperform | Wedbush | |
| 2/7/2023 | Hold → Sell | Odeon | ||
| 9/30/2022 | $7.50 | Sell → Hold | Odeon | |
| 9/1/2022 | Mkt Perform → Underperform | Raymond James | ||
| 8/18/2022 | $5.00 | Neutral → Underperform | Wedbush | |
| 8/16/2022 | $7.50 | Hold → Sell | Odeon |
Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b trial; multiple data readouts of existing COVID-19 vaccine Phase 2 trials expected during fourth quarter 2024 Gedeptin® on track to advance into Phase 2 clinical trial for first recurrent head and neck cancer in the first half of 2025 GEO-MVA Mpox vaccine advancing with cGMP clinical batch anticipated during fourth quarter 2024 Company to host conference call and webcast today at 4:30 p.m. ET ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced financial results for the third quarter end
IRVING, Texas, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Reaktr, the global business unit of Exela Technologies, Inc. ("Exela" or the "Company") (NASDAQ:XELA, XELAP)), XBP Europe ("XBP") (NASDAQ:XBP, XBPEW)), and a member of the Oracle Partner Network (OPN), today announced the availability of SecAi on Oracle Cloud Infrastructure (OCI) and in the Oracle Cloud Marketplace. A pivotal component of Reaktr's innovative AI cybersecurity suite, SecAi provides enterprises with a fully configurable generative AI validation framework that supports 120+ large language models (LLMs). Enterprises can now validate components, including training data, LLMs of choice, enterprise integrations, and responsible int
Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024 Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today provided an update to its shareholders on the utilization of its Equity Line of Credit ("ELOC") and At-the-Market ("ATM") facility, as well as its outstanding number of shares. Equity Issuance Update as of End of Day November 7, 2024: Total number of shares traded since ELOC and ATM Activation: 153,085,471 Total number of shares sold via ELOC and ATM: 11,920,744, representing approximately 8% of total traded shares
Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b trial; multiple data readouts of existing COVID-19 vaccine Phase 2 trials expected during fourth quarter 2024 Gedeptin® on track to advance into Phase 2 clinical trial for first recurrent head and neck cancer in the first half of 2025 GEO-MVA Mpox vaccine advancing with cGMP clinical batch anticipated during fourth quarter 2024 Company to host conference call and webcast today at 4:30 p.m. ET ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced financial results for the third quarter end
Eight Consecutive Quarters of Year-Over-Year Gross Originations Growth Expecting A Strong Holiday SeasonUpdates Full Year 2024 Gross Originations Outlook PLANO, Texas, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Katapult Holdings, Inc. ("Katapult" or the "Company") (NASDAQ:KPLT), an e-commerce-focused financial technology company, today reported its financial results for the third quarter ended September 30, 2024. "We are continuing to grow across key financial and operating metrics including gross originations and revenue, and we believe we are laying the foundation for the long-term success of Katapult," said Orlando Zayas, CEO of Katapult. "As we have grown the business, we've also meaning
GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that it will report third quarter 2024 financial results on Tuesday, November 12, 2024, after the close of U.S. markets. Following the release, management will host a live conference call and webcast, including Q&A, at 4:30 p.m. ET to provide a corporate update and discuss financial results. Conference Call Details To access the live conference call, participants may register here. The live audio webcast of the call will be available
Investors with a lot of money to spend have taken a bearish stance on GameStop (NYSE:GME). And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GME, it often means somebody knows something is about to happen. So how do we know what these investors just did? Today, Benzinga's options scanner spotted 21 uncommon options trades for GameStop. This isn't normal. The overall sentiment of these big-money traders is split between 4% bullish and 90%, bearish. Out of all of the special optio
EF Hutton analyst Jason Kolbert initiates coverage on Geovax Labs (NASDAQ:GOVX) with a Buy rating and announces Price Target of $18.
10-Q - GeoVax Labs, Inc. (0000832489) (Filer)
8-K - Exela Technologies, Inc. (0001620179) (Filer)
8-K - Evofem Biosciences, Inc. (0001618835) (Filer)
Aditxt, Inc. ("Aditxt" or the "Company") (NASDAQ:ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced the appointment of Sylvia Hermina to its Board of Directors. With over 20 years of experience advising public companies on corporate governance, mergers and acquisitions, and shareholder relations, Ms. Hermina brings a wealth of expertise in fostering effective and impactful engagement between management teams and stakeholders. Throughout her career, Ms. Hermina has advised NYSE and NASDAQ listed companies on governance best practices and developed communication strategies tailored to retail and institutional investors. As Senior Vice
Pitney Bowes Inc. (NYSE:PBI) ("Pitney Bowes" or the "Company"), a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the world, today announced the appointment of Lance Rosenzweig as the Company's permanent Chief Executive Officer ("CEO"), effective immediately. The Company's Board of Directors (the "Board") carried out an extensive CEO search process that was supported by a nationally recognized executive recruiting firm and included both internal and external candidates. After assessing Mr. Rosenzweig's considerable contributions as interim CEO and his track record of value creation at Pitney Bowes and at other co
Aditxt, Inc. ("Aditxt" or the "Company") (NASDAQ:ADTX), an innovation platform dedicated to discovering, developing, and deploying promising health innovations, today announced that its subsidiary, Pearsanta, Inc. ("Pearsanta"), appointed Christoper Mitton as President. Christopher Mitton brings over 20 years of leadership experience in the medical diagnostics industry, with a strong focus on personalized healthcare and molecular oncology diagnostics. He has a proven track record in building and leading successful commercial operations, underpinned by his deep expertise in product commercialization, business development, and strategic sales and marketing. Mr. Mitton continues to serve as
Alliance Global Partners initiated coverage of GeoVax Labs with a rating of Buy and set a new price target of $15.00
ROTH MKM initiated coverage of GeoVax Labs with a rating of Buy and set a new price target of $20.00
Wedbush reiterated coverage of GameStop with a rating of Underperform and set a new price target of $6.20 from $6.50 previously
4 - GameStop Corp. (0001326380) (Issuer)
4 - GameStop Corp. (0001326380) (Issuer)
4 - GameStop Corp. (0001326380) (Issuer)
SC 13G - Toughbuilt Industries, Inc (0001668370) (Subject)
SC 13D/A - GameStop Corp. (0001326380) (Subject)
SC 13D/A - GameStop Corp. (0001326380) (Subject)
4 - GeoVax Labs, Inc. (0000832489) (Issuer)
4 - Toughbuilt Industries, Inc (0001668370) (Issuer)
4 - GameStop Corp. (0001326380) (Issuer)